Gut microbiome studies in CKD: opportunities, pitfalls and therapeutic potential

[1]  M. Vidali,et al.  Probiotics-Supplemented Low-Protein Diet for Microbiota Modulation in Patients with Advanced Chronic Kidney Disease (ProLowCKD): Results from a Placebo-Controlled Randomized Trial , 2022, Nutrients.

[2]  M. Essa,et al.  Mechanistic Insights into the Link between Gut Dysbiosis and Major Depression: An Extensive Review , 2022, Cells.

[3]  Ying Yao,et al.  Gut Dysbiosis and Kidney Diseases , 2022, Frontiers in Medicine.

[4]  R. Vanholder,et al.  What If Not All Metabolites from the Uremic Toxin Generating Pathways Are Toxic? A Hypothesis , 2022, Toxins.

[5]  B. Meijers,et al.  Effects of an SGLT Inhibitor on the Production, Toxicity, and Elimination of Gut-Derived Uremic Toxins: A Call for Additional Evidence , 2022, Toxins.

[6]  A. Vlahou,et al.  Microbiome in Chronic Kidney Disease (CKD): An Omics Perspective , 2022, Toxins.

[7]  Bao Sun,et al.  Gut Microbiota: An Important Player in Type 2 Diabetes Mellitus , 2022, Frontiers in Cellular and Infection Microbiology.

[8]  D. Magistro,et al.  Systematic Review of the Effects of Exercise and Physical Activity on the Gut Microbiome of Older Adults , 2022, Nutrients.

[9]  J. Raes,et al.  The Effect of ß-Glucan Prebiotic on Kidney Function, Uremic Toxins and Gut Microbiome in Stage 3 to 5 Chronic Kidney Disease (CKD) Predialysis Participants: A Randomized Controlled Trial , 2022, Nutrients.

[10]  A. Scorilas,et al.  Third-Generation Sequencing: The Spearhead towards the Radical Transformation of Modern Genomics , 2021, Life.

[11]  R. Paredes,et al.  Gut microbiome in hemodialysis patients treated with calcium acetate or treated with sucroferric oxyhydroxide: a pilot study , 2021, International Urology and Nephrology.

[12]  Luis Pedro Coelho,et al.  Combinatorial, additive and dose-dependent drug–microbiome associations , 2021, Nature.

[13]  David W. Johnson,et al.  Synbiotics Easing Renal Failure by Improving Gut Microbiology II (SYNERGY II): A Feasibility Randomized Controlled Trial , 2021, Nutrients.

[14]  K. Kalantar-Zadeh,et al.  Novel intestinal dialysis interventions and microbiome modulation to control uremia , 2021, Current opinion in nephrology and hypertension.

[15]  W. van Biesen,et al.  Gut Microbiota and Their Derived Metabolites, a Search for Potential Targets to Limit Accumulation of Protein-Bound Uremic Toxins in Chronic Kidney Disease , 2021, Toxins.

[16]  J. Raes,et al.  Gut Microbiome Profiling Uncovers a Lower Abundance of Butyricicoccus in Advanced Stages of Chronic Kidney Disease , 2021, Journal of Personalized Medicine.

[17]  L. Chang,et al.  Effects of Low Protein Diet on Modulating Gut Microbiota in Patients with Chronic Kidney Disease: A Systematic Review and Meta-analysis of International Studies , 2021, International journal of medical sciences.

[18]  V. Kon,et al.  Biotic Supplements in Patients With Chronic Kidney Disease: Meta-Analysis of Randomized Controlled Trials. , 2021, Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation.

[19]  J. Nicolas,et al.  Sequencing DNA with nanopores: Troubles and biases , 2021, PloS one.

[20]  Zheng Feng,et al.  Association between gut dysbiosis and chronic kidney disease: a narrative review of the literature , 2021, The Journal of international medical research.

[21]  Won Kim,et al.  Effects of Probiotics, Prebiotics, and Synbiotics on Uremic Toxins, Inflammation, and Oxidative Stress in Hemodialysis Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials , 2021, Journal of clinical medicine.

[22]  N. Tangri,et al.  A randomized double-blind cross-over trial to study the effects of resistant starch prebiotic in chronic kidney disease (ReSPECKD) , 2021, Trials.

[23]  U. Ijaz,et al.  The Impact of Enriched Resistant Starch Type-2 Cookies on the Gut Microbiome in Hemodialysis Patients: A Randomized Controlled Trial. , 2021, Molecular nutrition & food research.

[24]  Yen-Cheng Chen,et al.  Efficacy of AST-120 for Patients With Chronic Kidney Disease: A Network Meta-Analysis of Randomized Controlled Trials , 2021, Frontiers in Pharmacology.

[25]  S. Yen,et al.  Metagenomics: a path to understanding the gut microbiome , 2021, Mammalian Genome.

[26]  David A. Drew,et al.  Dietary fiber intake, the gut microbiome, and chronic systemic inflammation in a cohort of adult men , 2021, Genome medicine.

[27]  Hui Xu,et al.  Colonic dialysis can influence gut flora to protect renal function in patients with pre-dialysis chronic kidney disease , 2021, Scientific Reports.

[28]  J. Raes,et al.  Benchmarking microbiome transformations favors experimental quantitative approaches to address compositionality and sampling depth biases , 2021, Nature Communications.

[29]  Yuguang Zhou,et al.  Enlightening the taxonomy darkness of human gut microbiomes with a cultured biobank , 2020, Microbiome.

[30]  A. Bello,et al.  Fighting the unbearable lightness of neglecting kidney health: the decade of the kidney , 2021, Clinical kidney journal.

[31]  M. Jenab,et al.  The Role of Gut Barrier Dysfunction and Microbiome Dysbiosis in Colorectal Cancer Development , 2021, Frontiers in Oncology.

[32]  J. Raes,et al.  Short chain fatty acids and its producing organisms: An overlooked therapy for IBD? , 2021, EBioMedicine.

[33]  Yonghong Xiao,et al.  Alteration of the Gut Microbiome in Chronic Kidney Disease Patients and Its Association With Serum Free Immunoglobulin Light Chains , 2021, Frontiers in Immunology.

[34]  Youlian Zhou,et al.  Gut Microbiota Profile in Adult Patients with Idiopathic Nephrotic Syndrome , 2021, BioMed research international.

[35]  W. van Biesen,et al.  Free P-Cresyl Sulfate Shows The Highest Association With Cardiovascular Outcome In Chronic Kidney Disease. , 2021, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[36]  S. Eiam‐Ong,et al.  Protein-bound uremic toxin lowering strategies in chronic kidney disease: a systematic review and meta-analysis , 2021, Journal of Nephrology.

[37]  R. Masereeuw,et al.  Microphysiological Systems to Recapitulate the Gut-Kidney Axis. , 2021, Trends in biotechnology.

[38]  Miranda E. Kroehl,et al.  An exercise intervention alters stool microbiota and metabolites among older, sedentary adults , 2021, Therapeutic advances in infectious disease.

[39]  R. Saffery,et al.  Gut Microbiome Composition Remains Stable in Individuals with Diabetes-Related Early to Late Stage Chronic Kidney Disease , 2020, Biomedicines.

[40]  Yi-Ting Lin,et al.  Comparative Gut Microbiome Differences between Ferric Citrate and Calcium Carbonate Phosphate Binders in Patients with End-Stage Kidney Disease , 2020, Microorganisms.

[41]  D. Fouque,et al.  Effects of Fecal Microbiota Transplantation on Composition in Mice with CKD , 2020, Toxins.

[42]  Rui Li,et al.  Effects of Probiotic Preparations on Inflammatory Cytokines in Chronic Kidney Disease Patients: a Systematic Review and Meta-Analysis. , 2020, Current pharmaceutical biotechnology.

[43]  V. A. Zhirnov,et al.  Colon Microbiocenosis and Its Correction in Patients Receiving Programmed Hemodialysis , 2020, Sovremennye tekhnologii v meditsine.

[44]  K. Charlton,et al.  Associations Among Plant-Based Diet Quality, Uremic Toxins, and Gut Microbiota Profile in Adults Undergoing Hemodialysis Therapy. , 2020, Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation.

[45]  O. Pedersen,et al.  Gut microbiota in human metabolic health and disease , 2020, Nature Reviews Microbiology.

[46]  Lanjuan Li,et al.  Alterations of the Human Gut Microbiome in Chronic Kidney Disease , 2020, Advanced science.

[47]  F. Iraqi,et al.  Impact of host genetics on gut microbiome: Take‐home lessons from human and mouse studies , 2020, Animal models and experimental medicine.

[48]  S. Imoto,et al.  Metagenomic profiling of gut microbiome in early chronic kidney disease. , 2020, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[49]  G. Reid,et al.  The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of synbiotics , 2020, Nature Reviews Gastroenterology & Hepatology.

[50]  S. Hazen,et al.  Gut Microbiota and Cardiovascular Disease , 2020, Circulation research.

[51]  Trevor C. Charles,et al.  Microbiome definition re-visited: old concepts and new challenges , 2020, Microbiome.

[52]  Zhiming Lin,et al.  Dysbiosis of gut microbiota in adult idiopathic membranous nephropathy with nephrotic syndrome. , 2020, Microbial pathogenesis.

[53]  I. Narita,et al.  Effect of sucroferric oxyhydroxide on gastrointestinal microbiome and uremic toxins in patients with chronic kidney disease undergoing hemodialysis , 2020, Clinical and Experimental Nephrology.

[54]  L. Chang,et al.  Integrative metagenomic and metabolomic analyses reveal severity-specific signatures of gut microbiota in chronic kidney disease , 2020, Theranostics.

[55]  Xiping Xu,et al.  Aberrant gut microbiota alters host metabolome and impacts renal failure in humans and rodents , 2020, Gut.

[56]  Weihua Li,et al.  Drug repositioning by prediction of drug's anatomical therapeutic chemical code via network-based inference approaches , 2020, Briefings Bioinform..

[57]  M. Vaneechoutte,et al.  Isolation and Quantification of Uremic Toxin Precursor-Generating Gut Bacteria in Chronic Kidney Disease Patients , 2020, International journal of molecular sciences.

[58]  Sixiu Liu,et al.  Effect of probiotics on the intestinal microbiota of hemodialysis patients: a randomized trial , 2020, European Journal of Nutrition.

[59]  M. Vaneechoutte,et al.  Gut microbiota generation of protein-bound uremic toxins and related metabolites is not altered at different stages of chronic kidney disease. , 2020, Kidney international.

[60]  L. G. Vu,et al.  Global, regional, and national burden of chronic kidney disease, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 , 2020, The Lancet.

[61]  J. V. van Meurs,et al.  Diversity, compositional and functional differences between gut microbiota of children and adults , 2020, Scientific Reports.

[62]  Chenjiang Ying,et al.  Inulin-type fructan intervention restricts the increase in gut microbiome-generated indole in patients with peritoneal dialysis: a randomized crossover study. , 2020, The American journal of clinical nutrition.

[63]  T. van de Wiele,et al.  Supplementation of a propionate-producing consortium improves markers of insulin resistance in an in vitro model of gut-liver axis. , 2020, American journal of physiology. Endocrinology and metabolism.

[64]  L. Chang,et al.  Gut Microbiota as Diagnostic Tools for Mirroring Disease Progression and Circulating Nephrotoxin Levels in Chronic Kidney Disease: Discovery and Validation Study , 2020, International journal of biological sciences.

[65]  A. Desideri,et al.  Effect of Low-Protein Diet and Inulin on Microbiota and Clinical Parameters in Patients with Chronic Kidney Disease , 2019, Nutrients.

[66]  L. Öhman,et al.  A distinct gut microbiota composition in patients with ankylosing spondylitis is associated with increased levels of fecal calprotectin , 2019, Arthritis Research & Therapy.

[67]  F. Wijsbegeerte,et al.  Hype or hope? , 2019, Nature Reviews Microbiology.

[68]  P. Fu,et al.  Effects of probiotic supplements on the progression of chronic kidney disease: A meta‐analysis , 2019, Nephrology.

[69]  J. Raes,et al.  Synthetic ecology of the human gut microbiota , 2019, Nature Reviews Microbiology.

[70]  K. Campbell,et al.  Healthy Dietary Patterns and Incidence of CKD: A Meta-Analysis of Cohort Studies. , 2019, Clinical journal of the American Society of Nephrology : CJASN.

[71]  T. Siepmann,et al.  Dysbiosis of Gram-negative gut microbiota and the associated serum lipopolysaccharide exacerbates inflammation in type 2 diabetic patients with chronic kidney disease , 2019, Experimental and therapeutic medicine.

[72]  Dongmei Xu,et al.  Dysbiosis of the gut microbiome is associated with CKD5 and correlated with clinical indices of the disease: a case–controlled study , 2019, Journal of Translational Medicine.

[73]  H. Anders,et al.  Intestinal microbiome and fitness in kidney disease , 2019, Nature Reviews Nephrology.

[74]  Benjamin M Hillmann,et al.  Daily Sampling Reveals Personalized Diet-Microbiome Associations in Humans. , 2019, Cell host & microbe.

[75]  J. M. Rodríguez,et al.  Microbiota of human precolostrum and its potential role as a source of bacteria to the infant mouth , 2019, Scientific Reports.

[76]  N. Vaziri,et al.  Amylose resistant starch (HAM‐RS2) supplementation increases the proportion of Faecalibacterium bacteria in end‐stage renal disease patients: Microbial analysis from a randomized placebo‐controlled trial , 2019, Hemodialysis international. International Symposium on Home Hemodialysis.

[77]  Xin Xu,et al.  Metformin use and prostate cancer risk , 2019, Medicine.

[78]  Pengfei Guo,et al.  A meta-analysis of randomized controlled trials , 2019, Medicine.

[79]  J. Raes,et al.  The human microbiome in health and disease: hype or hope , 2019, Acta clinica Belgica.

[80]  M. Dunn,et al.  A human gut bacterial genome and culture collection for improved metagenomic analyses , 2019, Nature Biotechnology.

[81]  K. Kalantar-Zadeh,et al.  Constipation and risk of death and cardiovascular events. , 2019, Atherosclerosis.

[82]  J. Tap,et al.  Effects of the long-term storage of human fecal microbiota samples collected in RNAlater , 2019, Scientific Reports.

[83]  J. Raes,et al.  Gut microbiota dynamics and uraemic toxins: one size does not fit all , 2018, Gut.

[84]  L. Jia,et al.  Efficacy of Probiotics Supplementation On Chronic Kidney Disease: a Systematic Review and Meta-Analysis , 2018, Kidney and Blood Pressure Research.

[85]  D. Bolignano,et al.  Biotic Supplements for Renal Patients: A Systematic Review and Meta-Analysis , 2018, Nutrients.

[86]  S. Lal,et al.  The Human Gut Microbiome – A Potential Controller of Wellness and Disease , 2018, Front. Microbiol..

[87]  T. Meyer,et al.  Characteristics of Colon-Derived Uremic Solutes. , 2018, Clinical journal of the American Society of Nephrology : CJASN.

[88]  S. Ghosh,et al.  Sodium butyrate ameliorates insulin resistance and renal failure in CKD rats by modulating intestinal permeability and mucin expression , 2018, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[89]  Alice C. Smith,et al.  The association of physical function and physical activity with all-cause mortality and adverse clinical outcomes in nondialysis chronic kidney disease: a systematic review , 2018, Therapeutic advances in chronic disease.

[90]  B. Hayman,et al.  A narrative review of the literature about people with intellectual disability who identify as lesbian, gay, bisexual, transgender, intersex or questioning , 2018, Journal of intellectual disabilities : JOID.

[91]  D. Tripathy,et al.  KEYWORDS Chronic Kidney Disease (CKD), Haemodialysis, Glomerular Filtration Rate (GFR), End Stage Kidney Disease (ESKD), Kidney Disease Improving Global Outcomes (KDIGO) CKD Work Group. , 2018 .

[92]  J. Raes,et al.  Richness and ecosystem development across faecal snapshots of the gut microbiota , 2018, Nature Microbiology.

[93]  A. Ameur,et al.  Single molecule real-time (SMRT) sequencing comes of age: applications and utilities for medical diagnostics , 2018, Nucleic acids research.

[94]  R. Vanholder,et al.  Biochemical and Clinical Impact of Organic Uremic Retention Solutes: A Comprehensive Update , 2018, Toxins.

[95]  E. Mohammadi,et al.  Barriers and facilitators related to the implementation of a physiological track and trigger system: A systematic review of the qualitative evidence , 2017, International journal for quality in health care : journal of the International Society for Quality in Health Care.

[96]  M. Delgado-Rodríguez,et al.  Systematic review and meta-analysis. , 2017, Medicina intensiva.

[97]  Jun Wang,et al.  Quantitative microbiome profiling links gut community variation to microbial load , 2017, Nature.

[98]  M. Blaser,et al.  Microbiome perturbation by oral vancomycin reduces plasma concentration of two gut-derived uremic solutes, indoxyl sulfate and p-cresyl sulfate, in end-stage renal disease , 2017, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[99]  B. Meijers,et al.  The gut–kidney axis , 2017, Pediatric Nephrology.

[100]  Luis Pedro Coelho,et al.  Towards standards for human fecal sample processing in metagenomic studies , 2017, Nature Biotechnology.

[101]  Wei Zheng,et al.  Advanced glycation end products dietary restriction effects on bacterial gut microbiota in peritoneal dialysis patients; a randomized open label controlled trial , 2017, PloS one.

[102]  K. R. Kottapalli,et al.  Gut Microbiota-Dependent Trimethylamine-N-oxide and Serum Biomarkers in Patients with T2DM and Advanced CKD , 2017, Journal of clinical medicine.

[103]  Lippincott Williams Wilkins,et al.  Prevalence and incidence of epilepsy: A systematic review and meta-analysis of international studies , 2017, Neurology.

[104]  J. Raes,et al.  Practical considerations for large-scale gut microbiome studies , 2017, FEMS microbiology reviews.

[105]  C. Dutta,et al.  Geography, Ethnicity or Subsistence-Specific Variations in Human Microbiome Composition and Diversity , 2017, Front. Microbiol..

[106]  G. Reid,et al.  Expert consensus document: The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics , 2017, Nature Reviews Gastroenterology &Hepatology.

[107]  Paolo Piazza,et al.  Comprehensive comparison of Pacific Biosciences and Oxford Nanopore Technologies and their applications to transcriptome analysis , 2017, F1000Research.

[108]  Weili Zhang,et al.  Gut microbiota dysbiosis contributes to the development of hypertension , 2017, Microbiome.

[109]  H. Tilg,et al.  European consensus conference on faecal microbiota transplantation in clinical practice , 2017, Gut.

[110]  O. Djurdjev,et al.  Infection in advanced chronic kidney disease leads to increased risk of cardiovascular events, end-stage kidney disease and mortality. , 2016, Kidney international.

[111]  F. Hildebrand,et al.  Species–function relationships shape ecological properties of the human gut microbiome , 2016, Nature Microbiology.

[112]  L. Le Marchand,et al.  Characterization of the gut microbiome in epidemiologic studies: the multiethnic cohort experience. , 2016, Annals of epidemiology.

[113]  Morris A. Swertz,et al.  Population-based metagenomics analysis reveals markers for gut microbiome composition and diversity , 2016, Science.

[114]  J. Raes,et al.  Population-level analysis of gut microbiome variation , 2016, Science.

[115]  D. Cha,et al.  A Randomized, Controlled Trial of Oral Intestinal Sorbent AST-120 on Renal Function Deterioration in Patients with Advanced Renal Dysfunction. , 2016, Clinical journal of the American Society of Nephrology : CJASN.

[116]  Gang Zhao,et al.  Treatments for the Fifth Metacarpal Neck Fractures , 2016, Medicine.

[117]  David W. Johnson,et al.  Synbiotics Easing Renal Failure by Improving Gut Microbiology (SYNERGY): A Randomized Trial. , 2016, Clinical journal of the American Society of Nephrology : CJASN.

[118]  R. Milo,et al.  Revised Estimates for the Number of Human and Bacteria Cells in the Body , 2016, bioRxiv.

[119]  K. Verbeke,et al.  The Influence of CKD on Colonic Microbial Metabolism. , 2015, Journal of the American Society of Nephrology : JASN.

[120]  G. Beck,et al.  Randomized Placebo-Controlled EPPIC Trials of AST-120 in CKD. , 2015, Journal of the American Society of Nephrology : JASN.

[121]  M. Woodward,et al.  Kidney measures beyond traditional risk factors for cardiovascular prediction: A collaborative meta-analysis , 2015, The lancet. Diabetes & endocrinology.

[122]  P. Savelkoul,et al.  The Effect of Sampling and Storage on the Fecal Microbiota Composition in Healthy and Diseased Subjects , 2015, PloS one.

[123]  Rui Li,et al.  Whole transcriptome analysis with sequencing: methods, challenges and potential solutions , 2015, Cellular and Molecular Life Sciences.

[124]  Jennifer M. Fettweis,et al.  The truth about metagenomics: quantifying and counteracting bias in 16S rRNA studies , 2015, BMC Microbiology.

[125]  Angela C. Poole,et al.  Human Genetics Shape the Gut Microbiome , 2014, Cell.

[126]  R. Vanholder,et al.  The uremic toxicity of indoxyl sulfate and p-cresyl sulfate: a systematic review. , 2014, Journal of the American Society of Nephrology : JASN.

[127]  Glenn R. Gibson,et al.  The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic , 2014 .

[128]  Jens Roat Kultima,et al.  An integrated catalog of reference genes in the human gut microbiome , 2014, Nature Biotechnology.

[129]  T. Sharpton.  An introduction to the analysis of shotgun metagenomic data , 2014, Front. Plant Sci..

[130]  P. Bork,et al.  Richness of human gut microbiome correlates with metabolic markers , 2013, Nature.

[131]  Chi Pang Wen,et al.  Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention , 2013, The Lancet.

[132]  C. Philippe,et al.  Bacteroides thetaiotaomicron and Faecalibacterium prausnitzii influence the production of mucus glycans and the development of goblet cells in the colonic epithelium of a gnotobiotic model rodent , 2013, BMC Biology.

[133]  G. Andersen,et al.  Chronic kidney disease alters intestinal microbial flora. , 2013, Kidney international.

[134]  David A Rasko,et al.  The human microbiome: from symbiosis to pathogenesis. , 2013, Annual review of medicine.

[135]  David W. Johnson,et al.  Pre-, Pro-, and Synbiotics: Do They Have a Role in Reducing Uremic Toxins? A Systematic Review and Meta-Analysis , 2012, International journal of nephrology.

[136]  S. Tims,et al.  Microbiota conservation and BMI signatures in adult monozygotic twins , 2012, The ISME Journal.

[137]  Heather Kertland,et al.  Ascertaining problems with medication histories. , 2012, The Canadian journal of hospital pharmacy.

[138]  T. Klaenhammer,et al.  Characterization of the Fecal Microbiota Using High-Throughput Sequencing Reveals a Stable Microbial Community during Storage , 2012, PloS one.

[139]  Katherine H. Huang,et al.  The Human Microbiome Project: A Community Resource for the Healthy Human Microbiome , 2012, PLoS biology.

[140]  Katherine H. Huang,et al.  A framework for human microbiome research , 2012, Nature.

[141]  Katherine H. Huang,et al.  Structure, Function and Diversity of the Healthy Human Microbiome , 2012, Nature.

[142]  Hua V. Lin,et al.  Butyrate and Propionate Protect against Diet-Induced Obesity and Regulate Gut Hormones via Free Fatty Acid Receptor 3-Independent Mechanisms , 2012, PloS one.

[143]  J. Clemente,et al.  Human gut microbiome viewed across age and geography , 2012, Nature.

[144]  N. Kyrpides,et al.  Direct Comparisons of Illumina vs. Roche 454 Sequencing Technologies on the Same Microbial Community DNA Sample , 2012, PloS one.

[145]  T. Meyer,et al.  Colonic contribution to uremic solutes. , 2011, Journal of the American Society of Nephrology : JASN.

[146]  S. Crawford,et al.  Constipation and risk of cardiovascular disease among postmenopausal women. , 2011, The American journal of medicine.

[147]  Marian Kelley,et al.  One size does not fit all. , 2011, Bioanalysis.

[148]  R. Vanholder,et al.  Prospective evaluation of the change of predialysis protein-bound uremic solute concentration with postdilution online hemodiafiltration. , 2010, Artificial organs.

[149]  Marcus J. Claesson,et al.  Composition, variability, and temporal stability of the intestinal microbiota of the elderly , 2010, Proceedings of the National Academy of Sciences.

[150]  K. Verbeke,et al.  Uremic toxins originating from colonic microbial metabolism. , 2009, Kidney international. Supplement.

[151]  Ian R. Holzman,et al.  Butyrate enhances the intestinal barrier by facilitating tight junction assembly via activation of AMP-activated protein kinase in Caco-2 cell monolayers. , 2009, The Journal of nutrition.

[152]  F. Schmidt.  Meta-Analysis , 2008 .

[153]  A. Sanabria,et al.  Randomized controlled trial. , 2005, World journal of surgery.

[154]  Z. Massy,et al.  Chronic kidney disease as cause of cardiovascular morbidity and mortality. , 2005, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[155]  K. Verbeke,et al.  Impairment of small intestinal protein assimilation in patients with end-stage renal disease: extending the malnutrition-inflammation-atherosclerosis concept. , 2004, The American journal of clinical nutrition.

[156]  Chi-Sen Chang,et al.  Colonic transit time in long-term dialysis patients. , 2004, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[157]  K. Verbeke,et al.  Evidence for impaired assimilation of protein in chronic renal failure. , 2003, Kidney international.

[158]  C. Baird.  The pilot study. , 2000, Orthopedic nursing.

[159]  K. Magnusson,et al.  Impaired intestinal barrier function measured by differently sized polyethylene glycols in patients with chronic renal failure. , 1991, Gut.

[160]  J. Cummings,et al.  The effect of meat protein and dietary fiber on colonic function and metabolism. II. Bacterial metabolites in feces and urine. , 1979, The American journal of clinical nutrition.

[161]  S. Elsden,et al.  The end products of the metabolism of aromatic amino acids by clostridia , 1976, Archives of Microbiology.

[162]  Prof. Dr. Vasu D. Appanna.  Human Microbes - The Power Within , 2018, Springer Singapore.

[163]  Glenn R. Gibson,et al.  The International Scientific Association for Probiotics and Prebiotics ( ISAPP ) consensus statement on the definition and scope of prebiotics , 2018 .

[164]  P. Devane,et al.  A CASE-CONTROLLED STUDY , 2014 .

[165]  Brenda R. Hemmelgarn,et al.  Notice , 2012, Kidney International Supplements.

[166]  Thilo Marauhn,et al.  Old Concepts and New Challenges , 2011 .

[167]  I. Harris,et al.  A Systematic Review and Meta-Analysis of Randomized Controlled Trials , 2010 .

[168]  J. Wardle,et al.  A randomized trial , 2008 .

[169]  Kdoqi Disclaimer.  K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[170]  Susumu Goto,et al.  KEGG: Kyoto Encyclopedia of Genes and Genomes , 2000, Nucleic Acids Res..

[171]  K. Magnusson,et al.  Increased intestinal permeability to differently sized polyethylene glycols in uremic rats: effects of low- and high-protein diets. , 1990, Nephron.

[172]  Supplemental Information 2: Kyoto Encyclopedia of genes and genomes. , 2022 .